Animal Models for Long COVID: Current Advances, Limitations, and Future Directions
Authors:
- 21 February 2025
- journal article
- review article
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (2) , e70237
Abstract
Long COVID (LC) represents a chronic, systemic, and often disabling condition that poses a significant ongoing threat to public health. Foundational scientific studies are needed to unravel the underlying mechanisms, with the ultimate goal of developing effective preventative and therapeutic strategies. Therefore, there is an urgent demand for animal models that can accurately replicate the clinical features of LC. This review integrates clinical epidemiological data to summarize the pathological changes in extrapulmonary systems involved in LC. Additionally, it critically examines the capacity of existing animal models, including nonhuman primates, genetically modified mice, and Syrian hamsters, to exhibit enduring postinfection symptoms that align with human clinical manifestations, and identifies key areas requiring further development. The objective is to offer insights that will aid in the development of next‐generation animal models, thereby accelerating our understanding of how acute respiratory viral infections transition into chronic conditions, and ensuring preparedness for future pandemics.Keywords
This publication has 124 references indexed in Scilit:
- Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 InfectionJAMA Internal Medicine, 2024
- Epidemiologic Features of Recovery From SARS-CoV-2 InfectionJAMA Network Open, 2024
- The prevalence, determinants, and consequences of post‐COVID in healthcare workers: A cross‐sectional surveyJournal of Medical Virology, 2024
- SARS‐CoV‐2 induces blood‐brain barrier and choroid plexus barrier impairments and vascular inflammation in miceJournal of Medical Virology, 2024
- Trials Will Evaluate Treatments for Long COVID Nervous System ProblemsJAMA, 2024
- Exploring gut–lung axis crosstalk in SARS‐CoV‐2 infection: Insights from a hACE2 mouse modelJournal of Medical Virology, 2024
- Generation and characterization of a humanized ACE2 mouse model to study long‐term impacts of SARS‐CoV‐2 infectionJournal of Medical Virology, 2024
- Efficacy of nirmatrelvir and ritonavir for post‐acute COVID‐19 sequelae beyond 3 months of SARS‐CoV‐2 infectionJournal of Medical Virology, 2023
- Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19JAMA Network Open, 2021
- Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy CasesJAMA Cardiology, 2020